BK virus-associated hemorrhagic cystitis in a pediatric lung transplant recipient
Okan Elidemir
Department of Pediatric Pulmonology, Baylor College of Medicine, Houston, TX, USA
Search for more papers by this authorI-Fen Chang
Department of Pharmacy, Texas Childrens’ Hospital, Houston, TX, USA
Search for more papers by this authorMarc G. Schecter
Department of Pediatric Pulmonology, Baylor College of Medicine, Houston, TX, USA
Search for more papers by this authorGeorge B. Mallory
Department of Pediatric Pulmonology, Baylor College of Medicine, Houston, TX, USA
Search for more papers by this authorOkan Elidemir
Department of Pediatric Pulmonology, Baylor College of Medicine, Houston, TX, USA
Search for more papers by this authorI-Fen Chang
Department of Pharmacy, Texas Childrens’ Hospital, Houston, TX, USA
Search for more papers by this authorMarc G. Schecter
Department of Pediatric Pulmonology, Baylor College of Medicine, Houston, TX, USA
Search for more papers by this authorGeorge B. Mallory
Department of Pediatric Pulmonology, Baylor College of Medicine, Houston, TX, USA
Search for more papers by this authorAbstract
Abstract: BKV was first postulated to be a potential pathogen in 1971 when it was isolated in the urine of a renal transplant recipient. The pathology of BKV is generally confined to the urinary tract. In renal transplant recipients, BKV has been associated with hemorrhagic cystitis, urethral stenosis, and interstitial nephritis. Reports of BKV infection in lung transplant recipients are limited to a few case reports in adult patients. A recent report revealed that up to 32% of adult lung transplant recipients may shed BKV in their urine without symptoms or renal dysfunction. To our knowledge, there are no published reports of pediatric lung transplant recipients with BKV-associated hematuria. We hereby report a case of BKV-induced hemorrhagic cystitis in a pediatric lung transplant recipient.
References
- 1 Shah KV, Daniel RW, Warszawski RM. High prevalence of anti-BK antibodies to BKV, an SV 40-related papoviruses, in residents in Maryland. J Infect Dis 1973: 128: 784–787.
- 2 Flaegstad T, Ronne K, Filipe AR, Traavik T. Prevalence of anti-BK virus antibody in Portugal and Norway. Scand J Infect Dis 1989: 21: 145–147.
- 3 Kazory A, Ducloux D. Renal transplantation and polyomavirus infection: Recent clinical facts and controversies. Transpl Infect Dis 2003: 5: 65–71.
- 4 Dubois V, Dutronc H, Lafon ME, et al. Latency and reactivation of JC virus in peripheral blood of human immunodeficiency virus type 1-infected patients. J Clin Microbiol 1997: 35: 2288–2292.
- 5 Shah KV. Human polyomavirus BKV and renal disease. Nephrol Dial Transplant 2000: 15: 754–755.
- 6 Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (BK) isolated from urine after renal transplantation. Lancet 1971: 1: 1253–1257.
- 7 Gardner SD, MacKenzie EF, Smith C, Porter AA. Prospective study of the human polyomavirus BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol 1984: 37: 578–586.
- 8 Li RM, Mannon RB, Kleiner D, et al. BK virus and SV 40 co-infection in polyomavirus nephropathy. Transplantation 2002: 74: 1497–1504.
- 9
Troffe J,
Gaber LW,
Stratta RJ, et al.
Polyomavirus in kidney and kidney–pancreas transplant recipients.
Transpl Infect Dis
2003: 5: 22–29.
10.1034/j.1399-3062.2003.00009.x Google Scholar
- 10 Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 2005: 79: 1277–1286.
- 11 Binet I, Nickeleit V, Hirsch HH, et al. Polyomavirus disease under new immunosuppressive drugs: A cause of renal graft dysfunction and graft loss. Transplantation 1999: 67: 918–922.
- 12 Howell DN, Smith SR, Butterly DW, et al. Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients. Transplantation 1999: 68: 1279–1288.
- 13 Nickeleit V, Hirsh HH, Binet IF, et al. Polyomavirus infection of renal allograft recipients: From latent infection to manifest disease. J Am Soc Nephrol 1999: 10: 1080–1089.
- 14 Pahari A, Rees L. BK virus associated renal problems – Clinical implications. Pediatr Nephrol 2003: 19: 743–748.
- 15 Bodganovic G, Ljungman P, Wang F, Dalianis T. Presence of human polyomavirus DNA in the peripheral circulation of bone marrow transplant patients with and without hemorrhagic cystitis. Bone Marrow Transplant 1996: 17: 573.
- 16 Goddard AG, Sara V. Late-onset hemorrhagic cystitis following bone marrow transplantation: A case report. Pediatr Hematol Oncol 1997: 14: 2735.
- 17 Arthur RR, Shah KV, Baust KJ, Santos GW, Saral R. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplant. N Engl J Med 1986: 315: 230–234.
- 18 Jani JC, Guo M, Siddiqui NH. Polyomavirus in a lung transplant patient. Arch Pathol Lab Med 2004: 128: 1463–1464.
- 19 Schwarz A, Mengel M, Haller H, Niedermeyer J. Polyoma virus nephropathy in native kidneys after lung transplantation. Am J Transplant 2005: 5: 2582–2585.
- 20 Shirit D, Nirit L, Shiran SI, et al. Progressive multifocal leukoencephalopathy in a lung transplant recipient. J Heart Lung Transplant 2003: 22: 946–950.
- 21 Thomas LD, Vilchez RA, White ZS, et al. A prospective longitudinal study of polyomavirus shedding in lung transplant recipients. J Infect Dis 2007: 195: 442–449.
- 22 Pappo O, Demetris AJ, Raikow RB, Randhawa PS. Human polyoma virus infection of renal allograft: Histopathologic diagnosis, clinical significance, and literature review. Mod Pathol 1996: 9: 105–109.
- 23 Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002: 13: 2145–2151.
- 24 Lautenschlager I, Halme L, Hockerstedt K, Krogerus L, Taskinen E. Cytomegalovirus infection of the liver transplant recipient: Virological, histological, immunological, and clinical observations. Transpl Infect Dis 2006: 8: 21–30.
- 25 Chemaly RF, Yen-Lieberman B, Chapman J, et al. Clinical utility of cytomegalovirus load in bronchoalveolar lavage in lung transplant recipients. Am J Transplant 2005: 5: 544–548.
- 26 Koskinen PK, Kallio EA, Tikkanen JM, Sihvola RK, Hayry PJ, Lemstrom KB. Cytomegalovirus infection and cardiac allograft vasculopathy. Transpl Infect Dis 1999: 1: 115–126.
- 27 Bjorang O, Tveitan H, Midvedt K, Broch LU, Scott H, Andresen PA. Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient. Nephrol Dial Transplant 2002: 17: 2023–2025.
- 28 Vianelli N, Renga M, Azzi A, et al. Sequential vidarabine infusion in the treatment of polyoma virus-associated acute haemorrhagic cystitis after bone marrow transplantation. Bone Marrow Transplant 2000: 25: 319–320.
Citing Literature
